article thumbnail

IWD: Spotlight on women in life sciences

pharmaphorum

How did you get into life sciences? Dr Doina Ionescu (DI): After completing my PhD in physics at the University of Southampton, I joined Merck as a research scientist in 1998. DI: Transitioning from being a research scientist to a mergers & acquisitions project manager was not easy. What has your career path been?

article thumbnail

SnoreStop NasoSpray is Voluntarily Recalled by Green Pharmaceuticals Due to Microbial Contamination

XTalks

FL OZ (9 mL) nasal spray bottles to be contaminated with the bacteria, Providencia rettgeri. Although seldom associated with human disease, it can lead to severe or life-threatening adverse events — such as bacteremia/sepsis, pneumonia, invasive fungal rhinosinusitis, or disseminated fungal infection — in immunocompromised individuals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

J&J Sues Baby Powder Researchers Over “Junk Litigation Opinions”

XTalks

The drugmaker is facing more than 38,000 talc-related lawsuits, mostly over its iconic baby powder which plaintiffs claim was contaminated with asbestos that caused ovarian cancer and mesothelioma. LTL is also asking the court to force the researchers to disclose the patients’ identities, according to Reuters.

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. Why are those important?

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

article thumbnail

GxP Best Practices for Safer, Smarter, Faster Clinical Research

Advarra

In the clinical research space, GxP is a set of quality regulations and guidelines designed to establish the safety, efficacy, and integrity of pharmaceuticals, medical devices, and clinical trials. GLP ensures the quality and integrity of non-clinical laboratory studies that support research for products regulated by government agencies.

article thumbnail

Advances in cell line development

Drug Discovery World

The market for cell line development is currently rising due to an increased focus by the life sciences sector on biopharmaceuticals and targeted therapies. According to Grand View Research, the global cell line development market was valued at $4.81 He has a master’s degree in Journalism from Newcastle University.